The Food and Drug Administration (FDA) has issued a warning to healthcare providers on the purchasing of counterfeit, unapproved, or otherwise unsafe prescription drugs from unauthorized or unlicensed distributors.

The purchasing and administration of these medications by healthcare providers may be putting patients at significant risk because many of these drugs could be fake, contaminated, ineffective, or otherwise unsafe. These drugs may have not been evaluated by the FDA for safety and efficacy and may not contain the appropriate amount of active ingredients, or could contain harmful ingredients.

RELATED: Counterfeit Botox Discovered in the U.S.

As of January 1, 2015, the Drug Supply Chain Security Act required all healthcare providers who dispense or administer prescription drugs to patients to purchase their prescription drugs only from authorized trading partners licensed by or registered with the state or federal government, as applicable. Providers can use the Verify Wholesale Drug Distributor Licenses website to see if a wholesale drug distributor is licensed in the state(s) where it is conducting business. Healthcare professionals are also encouraged to report any suspected criminal activity to the FDA’s Office of Criminal Investigations.

For more information call (888) 463-6332 or visit